Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

593 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tumor immunity is related to 18 F-FDG uptake in thymic epithelial tumor.
Imai H, Kaira K, Hashimoto K, Nitanda H, Taguchi R, Yanagihara A, Umesaki T, Yamaguchi O, Mouri A, Kawasaki T, Yasuda M, Kobayashi K, Sakaguchi H, Kuji I, Kagamu H. Imai H, et al. Among authors: yamaguchi o. Cancer Med. 2021 Sep;10(18):6317-6326. doi: 10.1002/cam4.4176. Epub 2021 Aug 7. Cancer Med. 2021. PMID: 34363337 Free PMC article.
[Hange-Shashin-to for preventing diarrhea during afatinib therapy].
Yamaguchi O, Kawashima A, Shiono A, Maeno Y, Ishikawa R, Masumoto A, Utsugi H, Daito H, Okano T, Murayama Y, Kobayashi K. Yamaguchi O, et al. Gan To Kagaku Ryoho. 2015 May;42(5):581-3. Gan To Kagaku Ryoho. 2015. PMID: 25981651 Japanese.
Clinical significance of primary prophylactic pegylated-granulocyte-colony stimulating factor after the administration of ramucirumab plus docetaxel in patients with previously treated non-small cell lung cancer.
Mouri A, Kaira K, Shiono A, Yamaguchi O, Murayama Y, Kobayashi K, Kagamu H. Mouri A, et al. Among authors: yamaguchi o. Thorac Cancer. 2019 Apr;10(4):1005-1008. doi: 10.1111/1759-7714.13022. Epub 2019 Mar 11. Thorac Cancer. 2019. PMID: 30859745 Free PMC article.
Different incidence of interstitial lung disease according to different kinds of EGFR-tyrosine kinase inhibitors administered immediately before and/or after anti-PD-1 antibodies in lung cancer.
Uchida T, Kaira K, Yamaguchi O, Mouri A, Shiono A, Miura Y, Hashimoto K, Nishihara F, Murayama Y, Kobayashi K, Kagamu H. Uchida T, et al. Among authors: yamaguchi o. Thorac Cancer. 2019 Apr;10(4):975-979. doi: 10.1111/1759-7714.13039. Epub 2019 Mar 12. Thorac Cancer. 2019. PMID: 30864291 Free PMC article.
Radiotherapy is an independent prognostic marker of favorable prognosis in non-small cell lung cancer patients after treatment with the immune checkpoint inhibitor, nivolumab.
Yamaguchi O, Kaira K, Hashimoto K, Mouri A, Miura Y, Shiono A, Nishihara F, Murayama Y, Noda SE, Kato S, Kobayashi K, Kagamu H. Yamaguchi O, et al. Thorac Cancer. 2019 Apr;10(4):992-1000. doi: 10.1111/1759-7714.13044. Epub 2019 Mar 19. Thorac Cancer. 2019. PMID: 30888716 Free PMC article.
593 results